Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.

[1]  L. Dawson,et al.  Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Yue Cao,et al.  Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  S. Lorentini,et al.  Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Hirokazu Takahashi,et al.  Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection. , 2013, Hepato-gastroenterology.

[5]  F. Piscaglia,et al.  Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. , 2013, World journal of gastroenterology.

[6]  G. Cabibbo,et al.  Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study. , 2012, World journal of hepatology.

[7]  E. Kunieda,et al.  Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Todd Pawlicki,et al.  An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  H. Won,et al.  Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. , 2012, International journal of radiation oncology, biology, physics.

[10]  T. Hashimoto,et al.  Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[11]  T. Hashimoto,et al.  Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. , 2011, International journal of radiation oncology, biology, physics.

[12]  Cynthia S. Johnson,et al.  Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[13]  Kazuhiro Suwa,et al.  Feasibility and efficacy of single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma 8 cm or more with portal vein tumor thrombus in combination with transcatheter arterial chemoembolization. , 2010, International journal of radiation oncology, biology, physics.

[14]  M. Tokita,et al.  Proton beam therapy for large hepatocellular carcinoma. , 2010, International journal of radiation oncology, biology, physics.

[15]  M. Tokita,et al.  Proton-Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis* , 2009, Strahlentherapie und Onkologie.

[16]  H. Sakurai,et al.  Proton beam therapy for hepatocellular carcinoma , 2009, Cancer.

[17]  K. Togashi,et al.  Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? , 2009, Radiology.

[18]  N. Fukumitsu,et al.  A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[19]  N. Kokudo,et al.  Assessment of liver function for safe hepatic resection , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[20]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[21]  K. Ohara,et al.  Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. , 2007, International journal of radiation oncology, biology, physics.

[22]  T. Hashimoto,et al.  Proton beam therapy for hepatocellular carcinoma with inferior vena cava tumor thrombus: report of three cases. , 2007, Japanese journal of clinical oncology.

[23]  T. Hashimoto,et al.  Proton beam therapy for hepatocellular carcinoma with limited treatment options , 2006, Cancer.

[24]  M. Makuuchi,et al.  Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. , 2006, Gastroenterology.

[25]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[26]  John Wong,et al.  Natural History of Untreated Nonsurgical Hepatocellular Carcinoma , 2005, The American Journal of Gastroenterology.

[27]  K. Kagei,et al.  Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients , 2005, Clinical Cancer Research.

[28]  Y. Tsunashima,et al.  Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[29]  J. Furuse,et al.  A phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Y. Nagao,et al.  A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years. , 2004, International journal of molecular medicine.

[31]  M. Rugge,et al.  Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma , 2004, Annals of surgery.

[32]  J. Geschwind,et al.  The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Makuuchi,et al.  One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.

[34]  Y. Nagao,et al.  The prognosis for life in an HCV hyperendemic area. , 2003, Gastroenterology.

[35]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[36]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[37]  K. Man,et al.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy , 1997, The British journal of surgery.

[38]  S. Fan,et al.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. , 1995, Archives of surgery.

[39]  S. Kawasaki,et al.  Surgery for small liver cancers. , 1993, Seminars in surgical oncology.

[40]  C. Scudamore,et al.  Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. , 1992, American journal of surgery.

[41]  K. Ohara,et al.  Irradiation synchronized with respiration gate. , 1989, International journal of radiation oncology, biology, physics.

[42]  R. Phillips,et al.  Primary neoplasms of the liver. Results of radiation therapy , 1960 .

[43]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[44]  Masatoshi Kudo,et al.  Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. , 2010, Oncology.

[45]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[46]  下山正徳.  National Cancer Institute-Common Toxicity Criteria , 1999 .

[47]  H. Tsujii,et al.  Clinical results of fractionated proton therapy. , 1993, International journal of radiation oncology, biology, physics.